Atrial fibrillation
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Age >18 years old; 2.Patients diagnosed with new-onset, paroxysmal, persistent or permanent atrial fibrillation by ECG or 24-hour Holter monitoring; 3.Patients or guardians agreed to the research plan and signed the informed consent.
Exclusion criteria
Exclusion criteria: 1.Active bleeding 2.History of intracranial hemorrhage 3.Gastrointestinal bleeding within 12 months prior to randomization 4.Severe hepatic and renal insufficiency 5.Pregnant or lactating women 6.Any situation in which the investigator determines that the subject is not suitable for anticoagulant therapy 7.Known allergy or intolerance to oral anticoagulants
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of bleeding events at 1-year follow-up;the accordance of stroke prophylaxis for AF according to current guidelines;the percentage of time in the target INR range (TTR) for patients using warfarin;the occurrence of minor bleeding events; | — |
Countries
China